Oryzon Genomics S.A. (ORY.MC)

EUR 2.66

(1.33%)

Revenue Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual revenue in 2023 was 14.19 Million EUR , down 0.0% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly revenue in 2024 Q3 was - EUR , down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported a annual revenue of - EUR in annual revenue 2022, down 0.0% from previous year.
  • Oryzon Genomics S.A. reported a annual revenue of - EUR in annual revenue 2021, down 0.0% from previous year.
  • Oryzon Genomics S.A. reported a quarterly revenue of - EUR for 2024 Q3, down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Oryzon Genomics S.A. (2023 - 2019)

Historical Annual Revenue of Oryzon Genomics S.A. (2023 - 2019)

Year Revenue Revenue Growth
2023 14.19 Million EUR 0.0%
2022 - EUR 0.0%
2021 - EUR 0.0%
2020 - EUR 0.0%
2019 - EUR 0.0%

Peer Revenue Comparison of Oryzon Genomics S.A.

Name Revenue Revenue Difference
Atrys Health, S.A. 201.56 Million EUR 92.959%
Biotechnologies Assets SA 3.9 Million EUR -263.103%
Pharma Mar, S.A. 158.15 Million EUR 91.027%
Laboratorios Farmaceuticos Rovi, S.A. 829.5 Million EUR 98.289%